| Field | Specification |
|---|---|
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Jurkat cells — an immortalized human T-lymphocyte cell line that immunology and cancer research draw on heavily — are the target of GenMute™ siRNA Transfection Reagent for Jurkat Cells, which arrives pre-optimized so that siRNA reaches them efficiently. Much of that research treats the line as a key model: acute T-cell leukemia, signaling through the T-cell receptor, apoptosis, and how chemokine receptors tied to viral entry, HIV among them, are expressed. Interleukin-2 (IL-2) production and immune activation pathways are studied in them as well.
Within this suspension format the reagent pairs high transfection efficiency with minimal cytotoxicity, a fit for gene silencing work, pathway analysis, and functional in vitro assays.
Specifications
| Transfection Type | siRNA Transfection |
|---|---|
| Application Setting | In Vitro |
| Pre-Optimized | Yes — Pre-Optimized for Specific Cell Type |
| Optimized Cell Line | Jurkat |
| Storage | Store at 4 °C. If stored properly, the product is stable for 24 months or longer |
Optimal Transfection Conditions
| Cell Culture Medium | 1640 Medium with 10% FBS |
|---|---|
| Cell confluency on the day of transfection | ~70% |
| Optimal siRNA Concentration | 40 nM |
| Diluent for siRNA and GenMute™ Reagent | 1 x GenMute™ Transfection Buffer |
| Incubation Time to Form GenMute™/siRNA Complex | ~15 min at RT |
| Maximal Silencing Timeline | 72 hrs |
| Reporter Gene Silencing Efficiency (% ) | Renilla Luciferase 80% |
Kit Contents
- GenMute™ Reagent, 1.0 mL, sufficient for ~833 reactions based on transfecting 10 pmol siRNA or miRNA mimics in a 24-well plate
- GenMute™ Transfection Buffer (5x), formulated for maximal transfection efficiency, 8.0 mL to make a 40 mL working solution
Applications
This siRNA transfection reagent supports gene silencing experiments including RNAi screening, target validation, pathway analysis, and functional genomics studies. Effective delivery of siRNA, miRNA, and other small RNA molecules.
Safety & Handling
Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Du J, Liao W, Wang H, et al.. MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration. Signal Transduct Target Ther (2023) 8(1), 351-351.. 10.1038/s41392-023-01575-5
Xu T, Ma Q, Li Y, et al.. A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer. Signal Transduct Target Ther (2022) 7(1), 354-354.. 10.1038/s41392-022-01182-w
Sladitschek-Martens H, Guarnieri A, Brumana G, et al.. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING. Nature (2022) 607(7920), 790-798.. 10.1038/s41586-022-04924-6
Meunier E, Dick M, Dreier R, et al.. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature (2014) 509(7500), 366-70.. 10.1038/nature13157